Delivery Order SPE2DR25D2014-SPE2DR26FA1Y6
- Not listed
- On August 14, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $1,496.28 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens. This non-competitive, firm fixed-price delivery order is set to be completed by August 15, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The award represents a discrete fulfillment under the company's broader contract vehicle with DLA. AmerisourceBergen Drug Corp, a...
- On January 7, 2026, the Defense Logistics Agency (DLA) awarded a delivery order valued at $1,265.92 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 ml pen injections. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of January 8, 2026 and performance to be executed in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. and serves as a critical pharmaceutical distributor for federal medical...
- On November 6, 2025, the Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens valued at $1,116.83. This firm fixed-price delivery order, which has an ultimate completion date of November 7, 2025, was competitively awarded with no set-aside designation. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a $11,891.76 delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Trulicity 3 mg/0.5 mL pens. This competitively awarded, firm fixed-price contract carries an ultimate completion date of December 12, 2025, with performance to occur at the vendor's corporate headquarters in Conshohocken, Pennsylvania. The award represents a non-set-aside procurement and is issued as a child order under a larger contract vehicle. This...
- On January 6, 2026, the Defense Logistics Agency awarded a delivery order valued at $2,215.30 to AmerisourceBergen Drug Corp for the supply of Trulicity 4.5 mg/0.5 ml pen injections. The award is a firm fixed-price contract with an ultimate completion date of January 7, 2026, and represents a non-set-aside, competitively awarded procurement. The contractor's place of performance is located in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen Drug Corp's larger...
- On January 8, 2026, the Defense Logistics Agency awarded a delivery order valued at $2,189.43 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pen injectors with 0.5 mL dosage units. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of January 9, 2026, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award was made on a full and open competitive basis with no set-aside designation....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 25, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pens valued at $1,744.44 with a firm fixed price contract structure. This delivery order is a non-set-aside competitive award with an ultimate completion date of November 26, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a single-transaction purchase of the diabetes...
- The Defense Logistics Agency awarded a $19,544.63 delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Trulicity 0.75 mg/0.5 ml pens (0.5 ml dosage). This is a firm fixed-price delivery order with no set-aside designation, demonstrating that the award was made through open competition. The contract calls for completion by January 6, 2026, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. As a child contract under a larger vehicle,...
- The Defense Logistics Agency awarded a $1,270.46 firm fixed-price delivery order to Amerisourcebergen Drug Corp on January 6, 2026, for the supply of Trulicity 0.75 mg/0.5 ml pen injections. This non-set-aside contract, which is expected to be completed by January 7, 2026, represents a task order under Amerisourcebergen's larger pharmaceutical supply relationship with the federal government. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where Amerisourcebergen...
- The Defense Logistics Agency awarded a delivery order valued at $1,053.77 to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 ml pen (0.5 ml) on December 31, 2025, with an ultimate completion date of January 2, 2026. This is a firm fixed price delivery order with no set-aside designation, executed under open competition. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- SPE2DR25D2014Indefinite Delivery Contract
- SPE2DR25D2014-SPE2DR26FA1Y6Delivery Order
On January 9, 2026, the Defense Logistics Agency awarded a delivery order valued at $11,296.66 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 ml pen (0.5 ml). This firm fixed-price delivery order, with an ultimate completion date of January 12, 2026, represents a non-competitive award under an existing contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor for this pharmaceutical supply delivery. The contract has no set-aside designation, indicating it was awarded on a full and open competitive basis. This delivery order is executed under AmerisourceBergen Drug Corp's parent company, Cencora, Inc.'s, Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical (SPE2DX), valued at up to $999,999,999.00 through December 31, 2031. Trulicity is a diabetes management pharmaceutical typically supplied to support military healthcare programs and veteran medical facilities. The DLA's pharmaceutical procurement strategy through this comprehensive IDC vehicle enables flexible delivery of brand-name and generic medications, specialty treatments, and related medical supplies across multiple therapeutic domains to sustain military medical operations globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.3k | 1/8/26 |